Follow
International Journal of Current Microbiology and Applied Sciences (IJCMAS)
IJCMAS is now DOI (CrossRef) registered Research Journal. The DOIs are assigned to all published IJCMAS Articles.
Index Copernicus ICI Journals Master List 2019 - IJCMAS--ICV 2019: 96.39 For more details click here
National Academy of Agricultural Sciences (NAAS) : NAAS Score: *5.38 (2020) [Effective from January 1, 2020]For more details click here

Login as a Reviewer

Indexed in



National Academy of Agricultural Sciences (NAAS)
NAAS Score: *5.38 (2020)
[Effective from January 1, 2020]
For more details click here

ICV 2019: 96.39
Index Copernicus ICI Journals Master List 2019 - IJCMAS--ICV 2019: 96.39
For more details click here

See Guidelines to Authors
Current Issues

Original Research Articles

PRINT ISSN : 2319-7692
Online ISSN : 2319-7706
Issues : 12 per year
Publisher : Excellent Publishers
Email : editorijcmas@gmail.com / submit@ijcmas.com
Editor-in-chief: Dr.M.Prakash
Index Copernicus ICV 2018: 95.39
NAAS RATING 2020: 5.38

Int.J.Curr.Microbiol.App.Sci.2016.5(10): 523-526
DOI: http://dx.doi.org/10.20546/ijcmas.2016.510.057


Co-infection of HBV in HIV Patients Attending the ICTC of Santhiram Medical College, Nandyal, Andhra Pradesh, India
S. Sreedevi1*, V. Aarthi2 and K. Saraswathi1
1Department of Microbiology, Santhiram Medical College, Nandyal, A.P, India
2Department of Microbiology, Kurnool Medical College, Kurnool, AP, India
*Corresponding author
Abstract:

The present hospital based study was carried out in order to assess the prevalence of HBV infection in HIV seropositive individuals attending ICTC of Santhiram Medical College and General Hospital, a tertiary care hospital in A.P, India. 8665 serum samples collected over a period of 6 months from individuals attending the ICTC were screened for anti HIV antibodies as per NACO protocol. Samples found to be reactive for HIV antibodies were tested for HBsAg by rapid card test as per manufacturers guidelines in serology section of Dept of Microbiology. Our study shows, out of 8665 HIV suspected cases 2.4% (211/8665) were reactive for HIV and prevalence of Hepatitis B co-infection was 8.5% (18/211). In our study the commonest risk factor for transmission of HBsAg was unprotected sex which was 61.1% (11/18). Maximum of co-infected patients were of age group 35 – 49 years, followed by   25 – 34 years. The rate of progression and complications from viral hepatitis are accelerated in patients with co-infections. After acquiring Hepatitis b infection HIV infected individuals are more likely to develop chronic Hepatitis B infections leading to hepatocellular carcinoma. This represents another potential co-morbidity for patients with HIV infections. Early diagnosis and treatment increase the longevity of HIV positive patients irrespective of CD4 counts.


Keywords: Co-infection,HBV in HIV Patients,HBsAg,hepatocellular carcinoma.
Download this article as Download

How to cite this article:

Sreedevi, S., V. Aarthi and Saraswathi, K. 2016. Co-infection of HBV in HIV Patients Attending the ICTC of Santhiram Medical College, Nandyal, Andhra Pradesh, India.Int.J.Curr.Microbiol.App.Sci. 5(10): 523-526. doi: http://dx.doi.org/10.20546/ijcmas.2016.510.057